Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE: 300832)
China
· Delayed Price · Currency is CNY 67.09
-0.15 (-0.22%)
Nov 12, 2024, 3:04 PM CST
Shenzhen New Industries Biomedical Engineering Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 1,851 | 1,654 | 1,328 | 973.7 | 939.15 | 772.61 | Upgrade
|
| Depreciation & Amortization | 151.85 | 151.85 | 116.48 | 97 | 79.15 | 52.96 | Upgrade
|
| Other Amortization | 27.34 | 27.34 | 15.68 | 13.4 | 11.79 | 6.68 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.05 | -0.05 | -0.62 | -0.1 | 0.25 | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.52 | 1.52 | 1.52 | 1.86 | 0.63 | 17.04 | Upgrade
|
| Loss (Gain) From Sale of Investments | -92.94 | -92.94 | -76.95 | -71.67 | -58.71 | -41.23 | Upgrade
|
| Provision & Write-off of Bad Debts | 10.78 | 10.78 | 14.32 | -7.37 | 11.53 | - | Upgrade
|
| Other Operating Activities | -174.89 | -9.03 | -50.41 | 26.55 | 29.89 | 2.83 | Upgrade
|
| Change in Accounts Receivable | -277.18 | -277.18 | -240.16 | -154.66 | -60.45 | -34.14 | Upgrade
|
| Change in Inventory | -136.49 | -136.49 | -229.95 | -227.73 | -222.51 | -42.36 | Upgrade
|
| Change in Accounts Payable | 84.02 | 84.02 | 162.12 | 10.03 | 119.02 | 99.56 | Upgrade
|
| Change in Other Net Operating Assets | - | - | -80.71 | 93.88 | 141.4 | - | Upgrade
|
| Operating Cash Flow | 1,449 | 1,418 | 962.39 | 773.22 | 976.65 | 831.73 | Upgrade
|
| Operating Cash Flow Growth | 18.61% | 47.37% | 24.47% | -20.83% | 17.42% | 18.49% | Upgrade
|
| Capital Expenditures | -385.7 | -322.2 | -403.22 | -342.94 | -254.82 | -327.11 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.11 | 0.09 | 0.66 | 0.24 | 1.78 | 0.41 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -16.62 | - | - | - | Upgrade
|
| Investment in Securities | -622.42 | -53.47 | -261.5 | -634.54 | -2,299 | - | Upgrade
|
| Other Investing Activities | 99.05 | 84.85 | 86.96 | 52.67 | 57.74 | 41.23 | Upgrade
|
| Investing Cash Flow | -908.96 | -290.73 | -593.72 | -924.57 | -2,494 | -285.46 | Upgrade
|
| Long-Term Debt Repaid | - | -4.11 | -4.05 | -3.59 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -4.11 | -4.11 | -4.05 | -3.59 | - | - | Upgrade
|
| Issuance of Common Stock | - | - | - | 129.56 | 1,284 | - | Upgrade
|
| Repurchase of Common Stock | -16.29 | -16.29 | -21.62 | - | - | - | Upgrade
|
| Common Dividends Paid | -786.66 | -548.21 | -471.78 | -413.4 | -618.98 | - | Upgrade
|
| Other Financing Activities | 15.83 | - | - | 0 | -11.79 | -8.31 | Upgrade
|
| Financing Cash Flow | -791.22 | -568.61 | -497.45 | -287.43 | 653.67 | -8.31 | Upgrade
|
| Foreign Exchange Rate Adjustments | 12.75 | 8.69 | -9.13 | -14 | -33.49 | -2.93 | Upgrade
|
| Net Cash Flow | -238.13 | 567.66 | -137.9 | -452.78 | -897.61 | 535.03 | Upgrade
|
| Free Cash Flow | 1,064 | 1,096 | 559.17 | 430.28 | 721.84 | 504.62 | Upgrade
|
| Free Cash Flow Growth | 30.78% | 96.02% | 29.96% | -40.39% | 43.05% | 20.98% | Upgrade
|
| Free Cash Flow Margin | 23.98% | 27.89% | 18.35% | 16.90% | 32.89% | 30.01% | Upgrade
|
| Free Cash Flow Per Share | 1.35 | 1.39 | 0.71 | 0.55 | 0.96 | 0.72 | Upgrade
|
| Cash Income Tax Paid | 276.61 | 192.82 | 80.06 | 200.54 | 181.52 | 140.03 | Upgrade
|
| Levered Free Cash Flow | 967.3 | 705.91 | 198.4 | 213.19 | 555.67 | 225.59 | Upgrade
|
| Unlevered Free Cash Flow | 967.55 | 706.18 | 198.57 | 213.29 | 555.67 | 225.59 | Upgrade
|
| Change in Net Working Capital | 56.94 | 237.38 | 266.09 | 309.04 | 61 | 25.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.